The results revealed the involvement of Smad1/5/9 downstream in the TGF-β pathway and the activation of the ERK pathway under TGF-β stimulation, suggesting a mechanism underlying PAS development and providing insights into the development of molecularly targeted therapeutics. Here, SMAD1 is linked to gonorrhea.